Brief: Cyclopharm Posts FY Prelim Net Loss Attributable A$17.2 Million
25/02/2026 10:20
Feb 25 (Reuters) - Cyclopharm Ltd CYC.AX: FY PRELIM OPERATING REVENUE A$32.3 MILLION FY PRELIM NET LOSS ATTRIBUTABLE A$17.2 MILLION Further company coverage: CYC.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cyclopharm
See all newsAustralia's Cyclopharm rises after Chinese medical groups back its Technegas
Australia's Cyclopharm gains most in 8-months on Technegas rollout deal
Australia's Cyclopharm rises on HY revenue forecast
Brief: Cyclopharm Forecasts 1H Global Revenue Of A$17.1 Million
Brief: Cyclopharm Says David Heaney To Retire As Non-Executive Chair